Jan 22, 2010 | Laboratory News, Laboratory Pathology
Pathologists and clinical laboratories can expect a new type of federal oversight One consequence following passage of the massive health bill now being considered by Congress is a significant expansion in the role of the Internal Revenue Service for certain healthcare activities. So writes Phil Galewitz and Christopher Weaver of Kaiser Health News about developments that are not auspicious for pathology and clinical laboratory testing. They note that the job of enforcing the legislative...
